Skip to content
healthcare.dev
Get a free key

RHAPSIDO

NDC 0078-1483, remibrutinib, tablet, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-1483
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1483 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REMIBRUTINIB25 mg/1

Pharmacologic classes

Bruton's Tyrosine Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
0078-1483-200007814832060 TABLET in 1 BOTTLE (0078-1483-20)
0078-1483-92000781483922 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE
0078-1483-930007814839330 TABLET in 1 BOTTLE (0078-1483-93)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e5e89bff-6ced-4165-acc5-fb13136b3a3d

  • NADAC price for package 00078148320

    GET /v1/drugs/nadac/00078148320

Use it

Look up 0078-1483 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1483 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-1483. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.